CatSci is a leading European small molecule CRO that supports top tier global pharmaceutical companies to deliver life-changing therapeutics to patients around the world.

CatSci is a leading European small molecule Contract Research Organization (CRO), with a core focus on process R&D in pre-clinical and early clinical phases. The company has six operational laboratories across two UK sites, has done business in 13 countries and works with four of the top five global pharmaceutical companies. The company currently employs nearly 100 people, of which 80 % hold a PhD degree.

CatSci is committed to developing economically and environmentally sustainable drug manufacturing processes that enable its global pharmaceutical customers to create affordable small molecule therapeutics to address critical public health challenges, including antimicrobial resistance, cancer, and mental health.

Headquarters

UNITED KINGDOM

Investment Year

2022

Status

CURRENT